Have a feature idea you'd love to see implemented?
Let us know!
CODX Co-Diagnostics Inc
Price (delayed)
$1.06
Market cap
$33.85M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.38
Enterprise value
$25.42M
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using
Highlights
The company's debt fell by 22% YoY and by 8% QoQ
The revenue has soared by 57% YoY but it has contracted by 20% from the previous quarter
The company's gross profit fell by 34% QoQ but it rose by 23% YoY
Co-Diagnostics's quick ratio has decreased by 48% YoY and by 24% QoQ
The equity has declined by 36% year-on-year and by 12% since the previous quarter
Key stats
What are the main financial stats of CODX
Market
Valuations
Earnings
Shares outstanding
31.93M
Market cap
$33.85M
Enterprise value
$25.42M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.53
Price to sales (P/S)
4.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.47
Revenue
$7.32M
EBIT
-$37.38M
EBITDA
-$36.03M
Free cash flow
-$26.84M
Per share
Balance sheet
Liquidity
EPS
-$1.38
Free cash flow per share
-$0.88
Book value per share
$2
Revenue per share
$0.24
TBVPS
$1.52
Total assets
$72.38M
Total liabilities
$8.6M
Debt
$2.37M
Equity
$63.78M
Working capital
$34.31M
Debt to equity
0.04
Current ratio
6.92
Quick ratio
6.53
Net debt/EBITDA
0.23
Margins
Efficiency
Dividend
EBITDA margin
-492.1%
Gross margin
49.3%
Net margin
-563.9%
Operating margin
-546.4%
Return on assets
-49.3%
Return on equity
-54.9%
Return on invested capital
-95.9%
Return on capital employed
-56.1%
Return on sales
-510.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CODX stock price
How has the Co-Diagnostics stock price performed over time
Intraday
1.92%
1 week
-3.64%
1 month
-17.19%
1 year
-25.87%
YTD
-20.3%
QTD
-15.2%
Financial performance
How have Co-Diagnostics's revenue and profit performed over time
Revenue
$7.32M
Gross profit
$3.61M
Operating income
-$40M
Net income
-$41.28M
Gross margin
49.3%
Net margin
-563.9%
The revenue has soared by 57% YoY but it has contracted by 20% from the previous quarter
Co-Diagnostics's operating margin has soared by 55% YoY but it has decreased by 29% from the previous quarter
The company's net margin rose by 38% YoY but it fell by 37% QoQ
The company's gross profit fell by 34% QoQ but it rose by 23% YoY
Growth
What is Co-Diagnostics's growth rate over time
Valuation
What is Co-Diagnostics stock price valuation
P/E
N/A
P/B
0.53
P/S
4.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.47
CODX's EPS is down by 10% since the previous quarter
The P/B is 83% below the 5-year quarterly average of 3.2 but 6% above the last 4 quarters average of 0.5
The equity has declined by 36% year-on-year and by 12% since the previous quarter
The P/S is 65% below the 5-year quarterly average of 12.7 and 12% below the last 4 quarters average of 5.0
The revenue has soared by 57% YoY but it has contracted by 20% from the previous quarter
Efficiency
How efficient is Co-Diagnostics business performance
CODX's return on sales has surged by 55% year-on-year but it is down by 30% since the previous quarter
CODX's return on equity is down by 38% year-on-year and by 23% since the previous quarter
The ROA has contracted by 34% YoY and by 22% from the previous quarter
CODX's return on invested capital is down by 34% year-on-year and by 30% since the previous quarter
Dividends
What is CODX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CODX.
Financial health
How did Co-Diagnostics financials performed over time
The current ratio has plunged by 51% YoY and by 24% from the previous quarter
Co-Diagnostics's quick ratio has decreased by 48% YoY and by 24% QoQ
The company's debt is 96% lower than its equity
The equity has declined by 36% year-on-year and by 12% since the previous quarter
The debt to equity is up by 33% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.